Baseline Characteristics Explain Differences in Effectiveness of Randomization to Daily Oral TDF/FTC PrEP Between Transgender Women and Cisgender Men Who Have Sex With Men in the IPrEx Trial

Overview

Journal J Acquir Immune Defic Syndr

Specialty Infectious Diseases

Date 2019 Jun 14

PMID 31192894

Citations 11

Authors

Megha L Mehrotra

Daniel Westreich

Vanessa M McMahan

Medellena Maria Glymour

Elvin Geng

Robert M Grant

David V Glidden

Affiliations

Soon will be listed here.

Citing Articles

Review protocol for a systematic review and meta-analysis on HIV inequities in transgender and non-binary populations.

Lucas R, Moodley R, Garcia Gutierrez J, Bambilla A, Singh D, Rogers H BMJ Open. 2025; 15(1):e087821.

PMID: 39773796 PMC: 11749687. DOI: 10.1136/bmjopen-2024-087821.

Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations.

Restar A, Minalga B, Quilantang M, Adamson T, Dusic E, van der Merwe L Curr HIV/AIDS Rep. 2023; 20(3):160-169.

PMID: 37012537 PMC: 10071255. DOI: 10.1007/s11904-023-00656-y.

Perceived influence of alcohol consumption, substance use, and mental health on PrEP adherence and condom use among PrEP-prescribed gay, bisexual, and other men-who-have-sex-with-men: a qualitative investigation.

Shuper P, Varatharajan T, Kinitz D, Gesink D, Joharchi N, Bogoch I BMC Public Health. 2022; 22(1):1875.

PMID: 36207757 PMC: 9540691. DOI: 10.1186/s12889-022-14279-2.

Impact of feminizing hormone therapy on tenofovir and emtricitabine plasma pharmacokinetics: a nested drug-drug interaction study in a cohort of Brazilian transgender women using HIV pre-exposure prophylaxis.

Cattani V, Moreira Jalil E, Eksterman L, Torres T, Cardoso S, Castro C J Antimicrob Chemother. 2022; 77(10):2729-2736.

PMID: 35815666 PMC: 9525093. DOI: 10.1093/jac/dkac229.

HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa.

Little K, Flomen L, Hanif H, Anderson S, Thurman A, Clark M AIDS Behav. 2022; 26(9):3099-3109.

PMID: 35360893 PMC: 9371991. DOI: 10.1007/s10461-022-03658-w.

References

Poteat T, Wirtz A, Radix A, Borquez A, Silva-Santisteban A, Deutsch M . HIV risk and preventive interventions in transgender women sex workers. Lancet. 2014; 385(9964):274-86. PMC: 4320978. DOI: 10.1016/S0140-6736(14)60833-3. View

Baeten J, Grant R . Use of antiretrovirals for HIV prevention: what do we know and what don't we know?. Curr HIV/AIDS Rep. 2013; 10(2):142-51. PMC: 3644362. DOI: 10.1007/s11904-013-0157-9. View

Poteat T, Reisner S, Radix A . HIV epidemics among transgender women. Curr Opin HIV AIDS. 2013; 9(2):168-73. PMC: 5947322. DOI: 10.1097/COH.0000000000000030. View

Balzer L . "All Generalizations Are Dangerous, Even This One."-Alexandre Dumas. Epidemiology. 2017; 28(4):562-566. PMC: 5488351. DOI: 10.1097/EDE.0000000000000665. View

Poteat T, German D, Flynn C . The conflation of gender and sex: Gaps and opportunities in HIV data among transgender women and MSM. Glob Public Health. 2016; 11(7-8):835-48. PMC: 4957661. DOI: 10.1080/17441692.2015.1134615. View

Lesko C, Buchanan A, Westreich D, Edwards J, Hudgens M, Cole S . Generalizing Study Results: A Potential Outcomes Perspective. Epidemiology. 2017; 28(4):553-561. PMC: 5466356. DOI: 10.1097/EDE.0000000000000664. View

Rudolph K, Schmidt N, Glymour M, Crowder R, Galin J, Ahern J . Composition or Context: Using Transportability to Understand Drivers of Site Differences in a Large-scale Housing Experiment. Epidemiology. 2017; 29(2):199-206. PMC: 5792307. DOI: 10.1097/EDE.0000000000000774. View

Baral S, Poteat T, Stromdahl S, Wirtz A, Guadamuz T, Beyrer C . Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 13(3):214-22. DOI: 10.1016/S1473-3099(12)70315-8. View

Deutsch M, Glidden D, Sevelius J, Keatley J, McMahan V, Guanira J . HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015; 2(12):e512-9. PMC: 5111857. DOI: 10.1016/S2352-3018(15)00206-4. View

10.

Nemoto T, Bodeker B, Iwamoto M . Social support, exposure to violence and transphobia, and correlates of depression among male-to-female transgender women with a history of sex work. Am J Public Health. 2011; 101(10):1980-8. PMC: 3222349. DOI: 10.2105/AJPH.2010.197285. View

11.

Dahabreh I, Robertson S, Steingrimsson J, Stuart E, Hernan M . Extending inferences from a randomized trial to a new target population. Stat Med. 2020; 39(14):1999-2014. DOI: 10.1002/sim.8426. View

12.

Sevelius J, Keatley J, Calma N, Arnold E . 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016; 11(7-8):1060-75. PMC: 10204128. DOI: 10.1080/17441692.2016.1154085. View

13.

Volk J, Marcus J, Phengrasamy T, Blechinger D, Nguyen D, Follansbee S . No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis. 2015; 61(10):1601-3. PMC: 4809999. DOI: 10.1093/cid/civ778. View

14.

Westreich D, Edwards J, Lesko C, Cole S, Stuart E . Target Validity and the Hierarchy of Study Designs. Am J Epidemiol. 2018; 188(2):438-443. PMC: 6357801. DOI: 10.1093/aje/kwy228. View

15.

Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

16.

Rudolph K, van der Laan M . Robust estimation of encouragement-design intervention effects transported across sites. J R Stat Soc Series B Stat Methodol. 2018; 79(5):1509-1525. PMC: 5784860. DOI: 10.1111/rssb.12213. View

17.

Lombardi E, Wilchins R, Priesing D, Malouf D . Gender violence: transgender experiences with violence and discrimination. J Homosex. 2002; 42(1):89-101. DOI: 10.1300/j082v42n01_05. View

18.

Mehrotra M, Amico K, McMahan V, Glidden D, Defechereux P, Guanira J . The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men. AIDS Behav. 2018; 22(11):3673-3680. PMC: 6492931. DOI: 10.1007/s10461-018-2151-0. View

19.

Fonner V, Dalglish S, Kennedy C, Baggaley R, OReilly K, Koechlin F . Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016; 30(12):1973-83. PMC: 4949005. DOI: 10.1097/QAD.0000000000001145. View